Kelly Ganjei, founder, president and chief executive officer of AmplifyBio, a biotechnology company developing cell and gene therapies, has been named one of the top 50 entrepreneurs in biotech for 2024 by Great Entrepreneurs, formerly The Business Report. As the CEO of AmplifyBio, Ganjei leads the New Albany-based company’s efforts to create pathways for novel treatment advances by integrating development, safety, characterization, and manufacturing solutions to advance medical breakthroughs, treatments, and cures for disease. A proven leader with 26 years of experience in the life science, venture capital and IT sectors, Ganjei has a strong track record of guiding companies through various stages of development, from start-up to rapid growth and into stable multinational operations. This year’s awardees were selected through a methodical process and careful consideration of each candidate’s career track record and industry contributions.

Prior to being named CEO of AmplifyBio, Ganjei was the CEO for Cognate BioServices, a leading contract development and manufacturing organization in the cell therapy space and the leading CDMO in autologous cell therapies. According to Great Entrepreneurs, “By combining scientific expertise with entrepreneurial spirit, these leaders are revolutionizing the development of treatments for conditions that have long eluded effective intervention. These leaders not only push the boundaries of scientific research but also navigate the complexities of bringing their innovations to market, ensuring that breakthroughs translate into accessible healthcare solutions. By fostering collaboration across academia, industry, and clinical practice, they create synergies that accelerate discovery and development processes, ultimately revolutionizing patient care and inspiring a healthier future worldwide.”